Understanding metromenorrhagia, its clinical documentation, and medical coding are crucial for accurate healthcare. This resource provides information on metromenorrhagia diagnosis, ICD-10 codes for abnormal uterine bleeding AUB, menorrhagia treatment, and managing prolonged or excessive menstruation. Learn about documenting metromenorrhagia symptoms, differential diagnosis, and relevant medical terminology for proper coding and billing. Find guidance on heavy menstrual bleeding HMB, its impact on patient care, and best practices for healthcare professionals.
Also known as
Excessive and frequent menstruation
Heavy menstrual bleeding occurring more frequently than normal.
Irregular menstrual bleeding
Menstrual bleeding at irregular intervals, sometimes including heavy flow.
Excessive and prolonged menstruation
Heavy menstrual bleeding lasting longer than usual.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the metromenorrhagia due to an underlying medical condition?
When to use each related code
| Description |
|---|
| Heavy, prolonged menses |
| Irregular, heavy bleeding |
| Bleeding between periods |
Coding menorrhagia (N50.1) without specifying the underlying cause when known leads to inaccurate data and potential DRG misassignments.
Confusing AUB (N93.8) with metrorrhagia (N92.1) can lead to incorrect coding, impacting quality metrics and reimbursement.
Insufficient documentation to support the diagnosis of metrorrhagia can cause coding errors and compliance issues during audits.
Patient presents with metromenorrhagia, characterized by prolonged or excessive uterine bleeding occurring at irregular intervals. The patient reports heavy menstrual bleeding (HMB), irregular periods (menorrhagia), and bleeding between periods (metrorrhagia). Duration of bleeding episodes varies, lasting longer than seven days, with cycle length fluctuating between 20 and 45 days. Symptoms include fatigue, weakness, and dysmenorrhea. Differential diagnosis includes endometrial polyps, uterine fibroids, adenomyosis, hormonal imbalances, coagulopathies, and endometrial hyperplasia or carcinoma. Pelvic examination reveals a normal-sized, non-tender uterus. Transvaginal ultrasound was performed to assess endometrial thickness and rule out structural abnormalities. Complete blood count (CBC) ordered to evaluate for anemia secondary to blood loss. Coagulation studies requested to exclude bleeding disorders. Initial management includes hormonal therapy with combined oral contraceptives or progestin-only options to regulate the menstrual cycle and reduce bleeding. Patient education provided on managing heavy menstrual flow and recognizing signs of anemia. Follow-up appointment scheduled in four weeks to assess treatment response and consider further diagnostic testing if necessary, including endometrial biopsy, if indicated based on ultrasound findings or lack of response to initial therapy. ICD-10 code NRR.8 assigned.